<SEC-DOCUMENT>0001428336-23-000005.txt : 20230210
<SEC-HEADER>0001428336-23-000005.hdr.sgml : 20230210
<ACCEPTANCE-DATETIME>20230210160119
ACCESSION NUMBER:		0001428336-23-000005
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230210
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230210
DATE AS OF CHANGE:		20230210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		23611670

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hqy-20230210.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:fda000f7-2668-4810-8794-b37fb50dca9e,g:6ac9371a-f328-4ee1-8801-2a5ce3187201,d:a228b8ff3d20463dab63aac9523410d1--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hqy-20230210</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF8yLTEtMS0xLTY0NTI3_e47efa5c-9992-4d12-8cd8-515ed9182cda">0001428336</ix:nonNumeric><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF8zLTEtMS0xLTY0NTI3_c1c86f4d-a37c-4b55-af63-bc0b52a5a445">false</ix:nonNumeric><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF80LTEtMS0xLTY2MjYy_a0fc5e8e-b3fd-4e27-8d1a-a6a397c55f79">01/31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hqy-20230210.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-10</xbrli:startDate><xbrli:endDate>2023-02-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia228b8ff3d20463dab63aac9523410d1_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:144%">Form <ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y184Mw_34666b39-1e33-4078-82b5-65a187357ec7">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMjU_8fc2ef7e-a2c4-42e5-8bd3-250c7e83d469">February 10, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6ZGQ4YjNlNTNlZjljNGI3ZGJhNzIxODA1YzhhNGI4ZjgvdGFibGVyYW5nZTpkZDhiM2U1M2VmOWM0YjdkYmE3MjE4MDVjOGE0YjhmOF8xLTAtMS0xLTY0NTI3_f9213d0a-5dce-40ef-ad38-8c4bc02e0337">HEALTHEQUITY, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTAtMS0xLTY0NTI3_73aed8fc-66bc-452f-834f-5ca9657823d5">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTItMS0xLTY0NTI3_eeabe0c5-dbff-4e49-becf-d1b18d920462">001-36568</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTQtMS0xLTY0NTI3_a3234ded-b4f9-4ddd-9344-db271dcae16f">52-2383166</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification Number)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMzU_f7bc20da-c58d-4f52-99d8-0d31f8c750ad">15 West Scenic Pointe Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMzk_37fc50b8-6380-4783-916e-a2f01000ad08">Suite 100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNDM_ad98a350-4729-4fee-b8ab-b510188b1381">Draper</ix:nonNumeric>, <ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNDc_229b9f5f-80b0-4615-bc46-b73ab86c08e4">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTA_2f5ca597-faff-46bd-9fbc-efd9c8c164f7">84020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTU_3abe499d-949a-425a-ad92-2bf99774eecb">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTk_7a10be43-55a9-4da3-8479-cb77cd3965a2">727-1000</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant&#8217;s Principal Executive Offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y182NjY_e35a36a3-7d95-45dd-8302-cde222253c10">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y183NTU_352f894d-095b-4e52-b278-145f33d8f860">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y184NDU_1d68a0d6-2e59-44ad-997a-281816508d32">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y185NTE_0830d535-9291-4962-a1f0-21a2e793989a">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTAtMS0xLTY0NTI3_c0936bcf-cb02-4fce-a83d-e2c465d7cf09">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTEtMS0xLTY0NTI3_094b4249-3db1-417e-80f0-26c98dc206e5">HQY</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTItMS0xLTY0NTI3_c9fcb365-8970-497b-8f19-48bad7fb70f7">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%"><ix:nonNumeric contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18xMzY0_c8ea0b42-d730-4127-9ff0-7e4c3131b6f9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%"> </span></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:138%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.03&#160;&#160;&#160;&#160;Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2023, the Board of Directors of HealthEquity, Inc. (the &#8220;Company&#8221;) approved and adopted amendments to the Company&#8217;s Amended and Restated By-laws (the &#8220;Bylaws&#8221;) to: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">implement certain additional procedural and disclosure requirements for director nominees and stockholders proposing director nominees and other business for consideration at the Company&#8217;s annual or special meetings of stockholders, including regarding the Securities and Exchange Commission&#8217;s recently adopted &#8220;universal proxy card&#8221; rules; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">require a stockholder directly or indirectly soliciting proxies from other stockholders to use a proxy card color other than white;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">reflect updates to requirements about stockholder lists at stockholder meetings and meeting adjournment notices, consistent with recent amendments to the Delaware General Corporation Law&#894; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">make certain technical and conforming revisions and clarifications.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary of the amendments to the Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws, a copy of which is filed as Exhibit 3.2 hereto.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="healthequityinc_amendedand.htm">Amended and Restated By-laws</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted in Inline XBRL)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:49.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HEALTHEQUITY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 10, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Tyson Murdock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyson Murdock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>healthequityinc_amendedand.htm
<DESCRIPTION>EX-3.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i84eb5b3676bb4b3283b599aa3b4f8009_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDED AND RESTATED BY-LAWS <br>OF <br>HEALTHEQUITY, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:9.7pt;text-decoration:underline"><br><br>OFFICES</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">REGISTERED OFFICE.  The registered office of the Corporation shall be established and maintained at the office of The Corporation Trust Company at 1209 Orange Street, Corporation Trust Center, Wilmington, DE, 19801, in the County of New Castle, in the State of Delaware, and said corporation shall be the registered agent of this Corporation, unless otherwise established by the Board of Directors and a certificate certifying the change is filed in the manner provided by statute.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">OTHER OFFICES.  The Corporation may also have offices at such other place or places as the Board of Directors may from time to time appoint or as the business of the Corporation may require.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:5.04pt;text-decoration:underline"><br><br>MEETINGS OF STOCKHOLDERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">PLACE OF MEETINGS.  All meetings of the stockholders shall be held in the offices of the Corporation in Draper, Utah, or at such other place as shall be determined by the Board of Directors and stated in the notice of the meeting or in a duly executed waiver of notice thereof. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as described in Section 10 of Article II of these By-laws in accordance with Section 211(a)(2) of the General Corporation Law of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delaware General Corporation Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">ANNUAL MEETING.  An annual meeting of the stockholders, for the election of directors and for the transaction of such other business as may properly come before the meeting, shall be held at such place, on such date, and at such time as the Board of Directors shall each year fix.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nominations of persons for election to the Board of Directors and the proposal of business to be transacted by the stockholders may be made at an annual meeting of stockholders pursuant to the Corporation&#8217;s notice of meeting (or any supplement thereto) delivered pursuant to Section 4 of Article II of these By-laws, (a) pursuant to the Corporation&#8217;s proxy materials, (b) by or at the direction of the Board of Directors or any authorized committee thereof, or (c) by any stockholder of record of the Corporation who was a stockholder of record at the time of the giving of the notice provided for in the following paragraph, who is entitled to vote at the meeting and who has complied with the notice procedures set forth in this Section 2, and with respect to the nominations of persons for election to the Board of Directors, who has complied with the requirements of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). For the avoidance of doubt, except to the extent specifically required by Rule 14a-19 under the Exchange Act, and the rules and regulations promulgated thereunder (including Rule 14a-19 thereunder), the foregoing clause (c) shall be the exclusive means for a stockholder to make nominations or propose business (other than business included in the Corporation&#8217;s proxy materials pursuant to Rule 14a-8 under the Exchange Act) at an annual meeting of the stockholders. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For nominations or other business to be properly brought before an annual meeting by a stockholder pursuant to clause (c) of the foregoing paragraph, </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation, </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) such business must be a proper matter for stockholder action, including under the Delaware General Corporation Law, </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3) if the stockholder, or the beneficial owner on whose behalf any such proposal or nomination is made, has provided the Corporation with a Solicitation Notice, as that term is defined in subclause (c)(iv) of this paragraph, such stockholder or beneficial owner must, in the case of a proposal, have delivered a proxy statement and form of proxy to holders of at least the percentage of the Corporation&#8217;s voting shares required under applicable law to carry any such proposal, or, in the case of a nomination or nominations, have delivered a proxy statement and form of proxy to holders of a percentage of the Corporation&#8217;s voting shares reasonably believed by such stockholder or beneficial holder to be sufficient to elect the nominee or nominees proposed to be nominated by such stockholder, and must, in either case, have included in such materials the Solicitation Notice and </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(4) if no Solicitation Notice relating thereto has been timely provided pursuant to this Section 2, the stockholder or beneficial owner proposing such business or nomination must not have solicited a number of proxies sufficient to have required the delivery of such a Solicitation Notice under this Section 2. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To be timely, a stockholder&#8217;s notice shall be delivered to or mailed and received by the Secretary at the principal executive offices of the Corporation not less than 90 nor more than 120 days in advance of the first anniversary of the preceding year&#8217;s annual meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Anniversary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, subject to the following sentence, that if the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 30 days after the Anniversary, or if no annual meeting was held in the preceding year, notice by the stockholder to be timely must be so delivered not later than the close of business on the later of (i) the 90th day prior to such annual meeting or (ii) the 10th day following the day on which public announcement of the date of such meeting is first made. In no event shall an adjournment or postponement of an annual meeting for which notice has been given commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice. Such stockholder&#8217;s notice shall set forth </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) as to each person whom the stockholder proposes to nominate for election or reelection as a director all information relating to such person as would be required to be disclosed in solicitations of proxies for the election of such nominees as directors or is otherwise required, in each case, pursuant to Section 14(a) under the Exchange Act and the rules and regulations promulgated thereunder, and such person&#8217;s written consent to being named in the proxy statement and to serve as a director if elected&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) as to any other business that the stockholder proposes to bring before the meeting, a brief description of such business, the text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend these By-laws, the language of the proposed amendment), reasons for conducting such business at the meeting and any material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the name and address of such stockholder, as they appear on the Corporation&#8217;s books, and of such beneficial owner, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the class and number of shares of the Corporation that are owned, directly or indirectly, beneficially and of record by such stockholder and such beneficial owner, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) in the case of the stockholder giving the notice, a representation that the stockholder is a holder of record of the stock of the Corporation at the time of the giving of the notice, will be entitled to vote at such meeting and will appear in person or by proxy at the meeting to propose such business or nomination, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) a representation whether or not the stockholder or the beneficial owner, if any, will or is part of a group which will (x) deliver a proxy statement and&#47;or form of proxy to holders of at least the percentage of the voting power of the Corporation&#8217;s outstanding capital stock required under applicable law to approve or adopt the proposal or, in the case of nominations, reasonably believed by such stockholder or beneficial owner to elect the nominee and&#47;or (y) otherwise solicit proxies or votes from stockholders in support of such proposal or nomination (in each case, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Solicitation Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v) a certification regarding whether such stockholder and beneficial owner, if any, have complied with all applicable federal, state and other legal requirements in connection with the stockholder&#8217;s and&#47;or beneficial owner&#8217;s acquisition of shares of capital stock or other securities of the Corporation and&#47;or the stockholder&#8217;s and&#47;or beneficial owner&#8217;s acts or omissions as a stockholder of the Corporation, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi) any other information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and&#47;or for the election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii) a copy of a fully completed and executed Director Questionnaire and a duly executed written representation and agreement by each person whom the stockholder proposes to nominate for election as a director, both in the forms required by the Corporation (which shall be provided upon written request made by a stockholder of record at the time of such request), and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii) the information required to be provided pursuant to Rule 14a-19 under the Exchange Act with respect to each person whom the stockholder proposes to nominate for election as a director&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) a description of any agreement, arrangement or understanding with respect to the nomination or proposal and&#47;or the voting of shares of any class or series of stock of the Corporation between or among the stockholder giving the notice, the beneficial owner, if any, on whose behalf the nomination or proposal is made, any of their respective affiliates or associates and&#47;or any others acting in concert with any of the foregoing (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">proponent persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) a description of any agreement, arrangement or understanding (including without limitation any contract to purchase or sell, acquisition or grant of any option, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">right or warrant to purchase or sell, swap or other instrument) to which any proponent person is a party, the intent or effect of which may be </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) to transfer to or from any proponent person, in whole or in part, any of the economic consequences of ownership of any security of the Corporation, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) to increase or decrease the voting power of any proponent person with respect to shares of any class or series of stock of the Corporation and&#47;or </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) to provide any proponent person, directly or indirectly, with the opportunity to profit or share in any profit derived from, or to otherwise benefit economically from, any increase or decrease in the value of any security of the Corporation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, a stockholder who has delivered a notice of nomination pursuant to this Section 2 shall, in accordance with Rule 14a-19, promptly certify to the Secretary of the Corporation, and notify the Secretary of the Corporation in writing, that such stockholder has met and complied with all of the requirements of these By-laws and of Rule 14a-19(a) (including for the avoidance of doubt Rule 14a-19(a)(3), which provides that a stockholder soliciting proxies in support of director nominees other than the Corporation&#8217;s nominees must solicit the holders of shares representing at least 67% of the voting power of shares entitled to vote on the election of directors) and shall deliver to the Corporation reasonable evidence of such compliance no later than five business days prior to the date of the applicable meeting of stockholders or any adjournment, postponement, recess or rescheduling thereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A stockholder providing notice of a proposed nomination for election to the Board of Directors or other business proposed to be brought before a meeting (whether given pursuant to this Section 2 or Section 3 of Article II of these By-laws) shall update and supplement such notice from time to time to the extent necessary so that the information provided or required to be provided in such notice shall be true and correct (x) as of the record date for determining the stockholders entitled to notice of the meeting and (y) as of the date that is fifteen (15) days prior to the meeting or any adjournment or postponement thereof, provided that if the record date for determining the stockholders entitled to vote at the meeting is less than fifteen (15) days prior to the meeting or any adjournment or postponement thereof, the information shall be supplemented and updated as of such later date. Any such update and supplement shall be delivered in writing to the Secretary of the Corporation at the principal executive offices of the Corporation not later than five (5) days after the record date for determining the stockholders entitled to notice of the meeting (in the case of any update and supplement required to be made as of the record date for determining the stockholders entitled to notice of the meeting), not later than ten (10) days prior to the date for the meeting or any adjournment or postponement thereof (in the case of any update or supplement required to be made as of fifteen (15) days prior to the meeting or adjournment or postponement thereof) and not later than five (5) days after the record date for determining the stockholders entitled to vote at the meeting, but no later than the date prior to the meeting or any adjournment or postponement thereof (in the case of any update and supplement required to be made as of a date less than fifteen (15) days prior the date of the meeting or any adjournment or postponement thereof). The failure to timely provide such update, supplement, evidence or additional information shall result in the nomination or proposal no longer being eligible for consideration at the annual meeting. If the stockholder fails to comply with the requirements of Rule 14a-19 (including because the stockholder fails to provide the Corporation with all information required by Rule 14a- 19), then the director nominees proposed by such stockholder shall be ineligible for election at the annual meeting. The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation and to determine the independence of such director under the Exchange Act and rules and regulations thereunder and applicable stock exchange rules. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything in these By-laws to the contrary, in the event that the number of directors to be elected to the Board of Directors is increased and there is no public announcement naming all of the nominees for director or specifying the size of the increased Board of Directors made by the Corporation at least 100 days prior to the Anniversary, a stockholder&#8217;s notice required by this By-law shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be received by the Secretary of the Corporation at the principal executive offices of the Corporation not later than the close of business on the tenth day following the day on which such public announcement is first made by the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Only persons nominated in accordance with the procedures set forth in this Section 2 or Section 3 or by or at the direction of the Board of Directors and with the requirements of the Exchange Act and the rules and regulations promulgated thereunder (including Rule 14a-19 thereunder) shall be eligible to serve as directors and such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with the procedures set forth in this Section 2 or Section 3. The chair of the meeting shall have the power and the duty to determine whether a nomination or any business proposed to be brought before the meeting has been made in accordance with the procedures set forth in these By-laws and with the requirements of the Exchange Act and the rules and regulations promulgated thereunder (including Rule 14a-19 thereunder) and, if any proposed nomination or business is not in compliance with these By-laws, to declare that such defective proposed business or nomination shall not be presented for stockholder action at the meeting and shall be disregarded. To facilitate the making of any such determination, any stockholder making a nomination pursuant to this Section 2 must, at the Corporation&#8217;s request, provide, within a reasonable time in advance of the meeting, written certifications as to his or her compliance and any evidentiary materials to support the basis for such certifications. Notwithstanding anything herein to the contrary, unless otherwise required by law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual or special meeting of stockholders of the Corporation to present a nomination or business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section 2, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of these By-laws, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">public announcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean disclosure (a) in a press release released by the Corporation, provided such press release is released by the Corporation following its customary procedures, is reported by the Dow Jones News Service, Associated Press or a comparable national news service, or is generally available on internet news sites, or (b) in a document publicly filed by the Corporation with the Securities and Exchange Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) pursuant to Section 13, 14 or 15(d) of the Exchange Act and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing provisions of this Section 2, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to matters set forth in this Section 2. Nothing in this Section 2 shall be deemed to affect any rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">SPECIAL MEETINGS.  Special meetings of the stockholders may only be called in the manner provided in the Amended and Restated Certificate of Incorporation and may be held either within or without the State of Delaware. The Board of Directors acting pursuant to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a resolution adopted by a majority of the Whole Board may postpone, reschedule or cancel any special meeting of stockholders previously called by the Board of Directors or the Chairman of the Board of Directors. Such meetings shall be held at the place, on the date and at the time as they or he shall fix. For purposes of these By-laws, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Whole Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the total number of authorized directors whether or not there exist any vacancies in previously authorized directorships. Business transacted at all special meetings shall be confined to the purpose or purposes stated in the Corporation&#8217;s notice of meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Corporation&#8217;s notice of meeting (a) by or at the direction of the Board of Directors or any committee thereof or (b) provided that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of record of the Corporation who is a stockholder of record at the time such notice is delivered to the Secretary of the Corporation as provided for in this paragraph, who shall be entitled to vote at the meeting, who delivers a written notice to the Secretary setting forth the information required in connection with nominations for annual meetings pursuant to Section 2 of this Article II, and who complies with the requirements of the Exchange Act, and the rules and regulations promulgated thereunder (including Rule 14a-19 thereunder). In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder entitled to vote in the election of directors may nominate a person or persons (as the case may be) for election to such position(s) as specified in the Corporation&#8217;s notice of meeting if the stockholder&#8217;s notice required by the preceding sentence shall be received by the Secretary at the principal executive offices of the Corporation not later than the close of business on the later of the 90th day prior to such special meeting or the 10th day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. No later than five (5) business days prior to the special meeting or any adjournment, postponement, recess or rescheduling thereof, a stockholder nominating individuals for election as a director shall provide the Corporation with reasonable evidence that such stockholder has met the requirements of Rule 14a-19 under the Exchange Act. The failure to timely provide such update, supplement, evidence or additional information shall result in the nomination no longer being eligible for consideration at the meeting. If the stockholder fails to comply with the requirements of Rule 14a-19 (including because the stockholder fails to provide the Corporation with all information required by Rule 14a- 19), then the director nominees proposed by such stockholder shall be ineligible for election at the meeting. In no event shall an adjournment or postponement of a special meeting commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described above. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To be in proper form, a request for a special meeting of stockholders submitted by one or more stockholders in accordance with the Amended and Restated Certificate of Incorporation must (a) be in writing and be delivered in person or by registered mail to the Secretary of the Corporation&#59; (b) specify in reasonable detail the purpose(s) of and the business proposed to be conducted at the special meeting&#59; (c) suggest a date for the special meeting, which date shall be no fewer than thirty (30) and no more than ninety (90) days from the date on which the request is delivered to the Secretary of the Corporation&#59; and (d) contain the information required for business to be brought properly by a stockholder before the annual meeting of stockholders as set forth in Section 2 of these Bylaws. If the Board of Directors determines a shareholder request for a special meeting complies with the Amended and Restated Certificate of Incorporation and the provisions of these Bylaws, the Board of Directors shall call and send notice of a special meeting for the purpose set forth in such request within thirty (30) days of receipt of the request. The Board of Directors shall determine the date for such special meeting and the record date for stockholders entitled to notice of and to vote at such meeting. Business transacted at a special meeting requested by stockholders shall be limited to the purpose(s) stated in the request, unless the Board of Directors submits additional matters to stockholders at any special meeting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">requested by stockholders. In making the decision to call a special meeting in response to stockholder requests, the Board of Directors shall have discretion as to the call and purposes of a meeting and may refuse to call a meeting (a) if the meeting request relates to an item of business that is not a proper subject for stockholder action under applicable law, or (b) for a purpose identical or similar to a purpose for which a previous special meeting was held in the previous ninety (90) days or an annual meeting to be held within ninety (90) days of the date the stockholder request is made.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing provisions of this Section 3, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to matters set forth in this Section 3.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">NOTICE OF MEETINGS.  Notice of the place, if any, date, and time of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purposes for which the meeting is called, shall be given not less than ten nor more than sixty days before the date on which the meeting is to be held, to each stockholder of record entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting, except as otherwise provided herein or required by law (meaning, here and hereinafter, as required from time to time by the Delaware General Corporation Law or the Amended and Restated Certificate of Incorporation). When a meeting is adjourned to another place, date or time, notice need not be given of the adjourned meeting if the time and place, if any, thereof, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and to vote at such adjourned meeting are announced at the meeting at which the adjournment is taken&#59; provided, however, that if the date of any adjourned meeting is more than thirty days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting, notice of the place, if any, date, and time of the adjourned meeting and the means of remote communications, if any, by which stockholders and proxyholders may be deemed present and to vote at such adjourned meeting shall be given in conformity herewith. At any adjourned meeting, any business may be transacted which might have been transacted at the original meeting&#59; but only those stockholders entitled to vote at the meeting as originally noticed shall be entitled to vote at any adjournment or adjournments thereof, unless the Board of Directors shall fix a new record date for the adjourned meeting pursuant to these By-laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">QUORUM.  Except to the extent that the presence of a larger number may be required by law, the Amended and Restated Certificate of Incorporation or the rules of any stock exchange upon which the Corporation&#8217;s securities are listed, the presence, in person or by proxy, of the holders of record of a majority of the voting power of the issued and outstanding shares of capital stock of the Corporation entitled to vote thereat shall constitute a quorum at all meetings of the stockholders, and every reference in these By-laws to a majority or other proportion of shares or stock (or the holders thereof) for the purposes of determining any quorum requirement or any requirement for stockholder consent or approval shall be deemed to refer to such majority or other proportion of the votes (or the holders thereof) then entitled to be cast in respect of such shares or capital stock. Once a quorum is present to organize a meeting, it shall not be broken by the subsequent withdrawal of any stockholders.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If a quorum shall fail to attend any meeting, the chairman of the meeting or, if the chairman of the meeting so elects, the holders of a majority of the voting power of the shares of stock entitled to vote who are present, in person or by proxy, may adjourn the meeting to another place, if any, date, or time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">ORGANIZATION.  The Chairman of the Board of Directors or, in his or her absence or disability, such person as the Board of Directors may have designated or, in the absence of, or upon the failure so to delegate such a person, the Chief Executive Officer of the Corporation, shall call to order any meeting of the stockholders and act as chairman of the meeting. The Secretary of the Corporation shall act as Secretary of all meetings of the stockholders. In the absence or disability of the Secretary of the Corporation, the secretary of the meeting shall be such person as the chairman or the Chief Executive Officer appoints.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">CONDUCT OF BUSINESS.   Except as otherwise required by law, the Amended and Restated Certificate of Incorporation or these By-laws, the chairman of the meeting shall, in addition to making any other determination that may be appropriate for the conduct of the meeting, have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in these By-laws and, if any proposed nomination or business is not in compliance with these By-laws, to declare that such defective proposal or nomination shall be disregarded. The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the chairman of the meeting. The Board of Directors may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chairman of the meeting shall have the right and authority to convene and (for any or no reason) to recess and&#47;or adjourn the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following&#58; (i) the establishment of an agenda or order of business for the meeting, (ii) rules and procedures for maintaining order at the meeting and the safety of those present&#59; (iii) limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine&#59; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof&#59; and (v) limitations on the time allotted to questions or comments by participants and on stockholder approvals. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meeting of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">PROXIES AND VOTING.  Each stockholder entitled to vote at a meeting of stockholders or to express consent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting and bearing a date not more than three years prior to said meeting, unless said instrument provides for a longer period. Any copy, facsimile telecommunication or other reliable reproduction of the writing or transmission created pursuant to this paragraph may be substituted or used in lieu of the original writing or transmission for any and all purposes for which the original writing or transmission could be used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation of the proxy or a new proxy bearing a later date. Each stockholder shall be entitled to vote, in accordance with the provisions of the Amended and Restated Certificate of Incorporation relating to shares of stock, the shares of stock registered in his name on the record date for the meeting, except as otherwise provided herein or required by law. Unless required by the Amended and Restated Certificate of Incorporation or applicable law, or determined by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">chairman of the meeting to be advisable, the vote on any question need not be by ballot. Every vote taken by ballots shall be counted by an inspector or inspectors appointed as provided herein.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At every meeting of stockholders duly called and held at which a quorum is present in all matters other than the election of directors, the vote of the holders of a majority of the voting power represented in person or by proxy at the meeting and entitled to vote on the matter shall be necessary to decide the question or election, unless the question is one upon which, by express provision of applicable law, of the rules or regulations of any stock exchange applicable to the Corporation, of any regulation applicable to the Corporation or its securities, of the Amended and Restated Certificate of Incorporation or of these By-laws, a different vote is required, in which case such express provision shall govern and control the decision of such question or election.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise provided by these By-laws, each director shall be elected by the vote of the majority of the votes cast with respect to that director&#8217;s election at any meeting for the election of directors at which a quorum is present&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if, as of a date that is fourteen (14) days in advance of the date the Corporation files its definitive proxy statement (regardless of whether or not thereafter revised or supplemented) with the SEC, the number of nominees exceeds the number of directors to be elected, the directors shall be elected by the vote of a plurality of the votes cast. For purposes of this Section 8 of these By-laws, a majority of votes cast shall mean that the number of votes cast &#8220;for&#8221; a director&#8217;s election exceeds the number of votes cast &#8220;against&#8221; that director&#8217;s election (with &#8220;abstentions&#8221; and &#8220;broker non-votes&#8221; not counted as a vote cast either &#8220;for&#8221; or &#8220;against&#8221; that director&#8217;s election).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares represented by a limited proxy (i.e., a proxy that by its terms, withholds authority or does not empower the holder to vote on the matter) will not be considered as part of the voting power present and entitled to vote with respect to that matter for determining whether the matter has a majority (or other required percentage) approval of the voting power present and entitled to vote on the matter. Abstentions (whether in person or by proxy) are counted as voting power present and entitled to vote on any proposal to which they relate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which white proxy card shall be reserved for the exclusive use by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">STOCKHOLDER LIST.  A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order and showing the address of each such stockholder and the number of shares registered in his name, shall be open to the examination of any such stockholder, for any purpose germane to the meeting for a period of at least ten days prior to the meeting, (provided, however, if the record date for determining the stockholders entitled to vote is less than ten (10) days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date) (a) on a reasonably accessible electronic network&#59; provided that the information required to gain access to such list is provided with the notice of meeting or (b) during ordinary business hours at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise provided by law, this list shall presumptively determine the identity of the stockholders entitled to examine the list of stockholders required by this Section 9 or entitled to vote at the meeting and the number of shares held by each of them.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">REMOTE COMMUNICATION.  If authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of Directors </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">may adopt, stockholders and proxy holders not physically present at a meeting of stockholders may, by means of remote communication&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">participate in a meeting of stockholders&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely by means of remote communication, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the Corporation shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings&#59; and (iii) if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">INSPECTORS OF ELECTION.  The Corporation may, and shall if required by law, in advance of any meeting of stockholders, appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof and to make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. In the event that no inspector so appointed or designated is able to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of his or her ability. The inspector or inspectors so appointed or designated shall (i) ascertain the number of shares of capital stock of the Corporation outstanding and the voting power of each such share, (ii) determine the shares of capital stock of the corporation represented at the meeting and the validity of proxies and ballots, (iii) count all votes and ballots, (iv) determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors, and (v) certify their determination of the number of shares of capital stock of the Corporation represented at the meeting and such inspectors&#8217; count of all votes and ballots. Such certification and report shall specify such other information as may be required by law. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may consider such information as is permitted by applicable law. No person who is a candidate for an office at an election may serve as an inspector at such election.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:0.38pt;text-decoration:underline"><br><br>BOARD OF DIRECTORS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">NUMBER AND TERM.  Subject to the Amended and Restated Certificate of Incorporation, the number of directors shall be fixed exclusively by resolution adopted by a majority of the Whole Board from time to time. Each director shall be elected to serve for a term that expires at the next regular annual meeting of the stockholders and when a successor is elected and has qualified, or at the time of the earlier death, resignation, removal or disqualification of the director. Directors need not be stockholders.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">CHAIRMAN.  The Board of Directors may, but shall not be required to, elect a Chairman of the Board of Directors who, if so elected, shall have the powers and perform </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such duties as provided in these By-laws and as the Board of Directors may from time to time prescribe. The Chairman of the Board shall preside at all meetings of the Board of Directors at which he or she is present. If the Chairman of the Board is not present at a meeting of the Board of Directors, a majority of the directors present at such meeting shall elect one (1) of their members to preside.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">RESIGNATION AND VACANCIES.  Any director or member of a committee may resign at any time. Such resignation shall be made to the Board of Directors, the Chairman of the Board of Directors, the Chief Executive Officer or the Secretary of the Corporation, in writing or by electronic transmission, and shall take effect at the time specified therein and if no time is specified, at the time of its receipt. The acceptance of a resignation shall not be necessary to make it effective unless otherwise expressly provided in the resignation. Vacancies (whether by death, resignation, disqualification, removal or other cause) and newly created directorships resulting from any increase in the authorized number of directors shall be filled in accordance with the Amended and Restated Certificate of Incorporation. Any director elected to fill a vacancy or newly created directorship shall hold office until the next regular annual meeting of the stockholders and until his or her successor shall be elected and qualified, or until his or her earlier death, resignation, disqualification or removal.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">REMOVAL.  Directors of the Corporation may be removed in the manner provided in the Amended and Restated Certificate of Incorporation and applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">COMMITTEES.  The Board of Directors may designate one or more committees, each committee to consist of one or more directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of any member of any committee and any alternate member in his or her place, the member or members of the committee present at the meeting and not disqualified from voting, whether or not he or she or they constitute a quorum, may by unanimous vote appoint another member or the Board of Directors to act at the committee meeting in the place of the absent or disqualified member.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any such committee, to the extent provided in the resolution of the Board of Directors establishing such committee, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it&#59; but no such committee shall have the power or authority in reference to the following matters&#58; (a) approving or adopting, or recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the Delaware General Corporation Law to be submitted to stockholders for approval or (b) adopting, amending or repealing any By-law of the Corporation. Each committee may determine the procedural rules for meeting and conducting its business and shall act in accordance therewith, except as otherwise provided herein, by a resolution of the Board of Directors designating such committee, or required by law. Adequate provision shall be made for notice to members of all meetings&#59; unless otherwise provided in such a resolution, at least a majority of the members shall constitute a quorum unless the committee shall consist of one or two members, in which event one member shall constitute a quorum&#59; and all matters shall be determined by a majority vote of the members present at a meeting of the committee at which a quorum is present.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">MEETINGS.  Regular meetings of the Board of Directors may be held without notice at such places and times as shall be determined from time to time by resolution of the Board of Directors and publicized among all directors. A notice of each regular meeting shall not be required. Special meetings of the Board of Directors may be called by the Chairman of the Board of Directors, if any, the Chief Executive Officer or by the Secretary of the Corporation if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">directed by the Board of Directors and shall be called by them on the written request of any two directors. Notice of the place, date, and time of each such special meeting shall be given each director by whom it is not waived by mailing notice not less than five days before the meeting or by sending notice by guaranteed overnight carrier not less than forty-eight hours before the meeting or by telephoning, hand delivering, telegraphing, faxing, e-mailing or sending by similar form of telecommunication notice or electronic transmission not less than twenty-four hours before the meeting. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting. Members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting of the Board of Directors (whether regular or special), or any committee, by means of conference telephone call or by means of other communications equipment by which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">QUORUM AND VOTING.  A majority of the Whole Board shall constitute a quorum for the transaction of business. If at any meeting of the Board of Directors there shall be less than a quorum present, a majority of those present may adjourn the meeting from time to time until a quorum is obtained, and no further notice thereof need be given other than by announcement at the meeting which shall be so adjourned. The affirmative vote of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors unless applicable law, the Amended and Restated Certificate of Incorporation or these By-laws shall require the vote of a greater number.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">COMPENSATION.  Directors shall be entitled to such compensation and fees (including reimbursement of reasonable expenses) for their services as directors or as members of committees as shall be authorized by resolution of the Board of Directors. Nothing herein contained shall be construed to preclude any director from serving the Corporation in any other capacity as an officer, agent or otherwise, and receiving compensation therefor.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">ACTION WITHOUT MEETING.  Any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee designated by the Board of Directors, may be taken without a meeting, if all members of the Board of Directors or of such committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or transmission or transmissions are filed with the minutes of proceedings of the Board of Directors or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">POWERS.  The Board of Directors shall have full power to manage the business and affairs of the Corporation&#59; and all powers of the Corporation, except those specifically reserved or granted to the stockholders by statute, the Amended and Restated Certificate of Incorporation or these By-laws, are hereby granted to and vested in the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:1.04pt;text-decoration:underline"><br><br>OFFICERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">OFFICERS.  The officers of the Corporation shall be a Chief Executive Officer, a President, one or more Vice Presidents, a Treasurer and a Secretary, all of whom shall be elected by the Board of Directors and shall hold office until their successors are elected and qualified or until their earlier resignation or removal. In addition, the Board of Directors may elect a Chairman and a Vice Chairman of the Board of Directors and such Assistant Secretaries and Assistant Treasurers, as it may deem proper. None of the officers of the Corporation need be directors. Two or more offices may be held by the same person.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">OTHER OFFICERS AND AGENTS.  The Board of Directors may appoint such other officers and agents as it may deem advisable, who shall hold office for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">CHIEF EXECUTIVE OFFICER.  The Chief Executive Officer of the Corporation shall be responsible for the general supervision of the business and affairs of the Corporation and, except as set forth in these By-laws or a resolution of the Board of Directors, of the Corporation&#8217;s other officers, and shall have and perform such other duties as from time to time may be assigned to him by the Board of Directors. He may sign, execute and acknowledge, in the name of the Corporation, deeds, mortgages, bonds, contracts or other instruments authorized by the Board of Directors, except in cases where the signing and execution thereof shall be expressly and exclusively delegated by the Board of Directors, or by these By-laws, to some other officer or agent of the Corporation&#59; and, in general, shall perform all duties incident to the office of Chief Executive Officer, and such other duties as from time to time may be assigned to him by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">PRESIDENT.  The President shall have such powers and shall perform such duties as from time to time shall be assigned to him by the Chief Executive Officer or the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">VICE-PRESIDENTS.  Each Vice-President shall have such powers and shall perform such duties as from time to time shall be assigned to him by the Chief Executive Officer or the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">TREASURER.  The Treasurer shall provide for the custody of the corporate funds and securities and shall keep full and accurate account of receipts and disbursements in books belonging to the Corporation. He shall collect and deposit all moneys and other valuables in the name and to the credit of the Corporation in such depositaries as may be designated by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Treasurer shall disburse the funds of the Corporation as may be ordered by the Board of Directors or the Chief Executive Officer, taking proper vouchers for such disbursements. He shall render to the Chief Executive Officer and the Board of Directors at meetings of the Board of Directors, or whenever the directors may request it, an account of all his transactions as Treasurer and of the financial condition of the Corporation. If required by the Board of Directors, he shall give the Corporation a bond for the faithful discharge of his duties in such amount and with such surety as the Board of Directors shall prescribe. In addition, the Treasurer shall have such further powers and perform such other duties incident to the office of Treasurer as from time to time are assigned to him by the Chief Executive Officer or the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">SECRETARY.  The Secretary shall be present at and give, or cause to be given, notice of all meetings of stockholders and directors, and all other notices required by law or by these By-laws, and in case of his absence or refusal or neglect so to do, any such notice may be given by any Assistant Secretary or by any person thereunto directed by the Chief Executive Officer, or by the Board of Directors. He shall record all the proceedings of the meetings of the Corporation and of the Board of Directors in books to be kept for such purpose, and shall perform such other duties as may be assigned to him by the Chief Executive Officer or the Board of Directors. He shall have the custody of the seal of the Corporation and shall affix the same to all instruments requiring it, when authorized by the Board of Directors or the Chief Executive Officer, and attest the same. The Secretary shall have such further powers and perform such other duties as prescribed from time to time by the Chief Executive Officer or the Board of Directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">ASSISTANT TREASURERS AND ASSISTANT SECRETARIES.  Each Assistant Treasurer and each Assistant Secretary, if any are elected, shall be vested with all the powers and shall perform all the duties of the Treasurer and Secretary, respectively, in the absence or disability of such officer, unless or until the Chief Executive Officer or the Board of Directors shall otherwise determine. Assistant Treasurers and Assistant Secretaries, if any, shall have such powers and shall perform such duties as shall be assigned to them, respectively, by the Chief Executive Officer or by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">REMOVAL AND REMOVAL.  Any officer of the Corporation may be removed at any time, with or without cause, by the Board of Directors. Any officer may resign at any time in the same manner prescribed under Section 3 of Article III of these By-laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">ACTION WITH RESPECT TO SECURITIES OF OTHER CORPORATIONS.  Unless otherwise directed by the Board of Directors, the Chief Executive Officer or any officer of the Corporation authorized by the Chief Executive Officer shall have the power to vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of stockholders of or with respect to any action of stockholders of any other corporation in which this Corporation may hold securities and otherwise to exercise any and all rights and powers which this Corporation may possess by reason of its ownership of securities in such other corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">CONTRACTS AND OTHER DOCUMENTS.  The Chief Executive Officer and the Secretary, or such other officer or officers as may from time to time be authorized by the Board of Directors or any other committee given specific authority in the premises by the Board of Directors during the intervals between the meetings of the Board of Directors, shall have power to sign and execute on behalf of the Corporation deeds, conveyances and contracts, and any and all other documents requiring execution by the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">DELEGATION OF DUTIES.  The Board of Directors may from time to time delegate the powers or duties of any officer to any other officers or agents, notwithstanding any provisions hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">VACANCIES.  The Board of Directors shall have the power to fill vacancies occurring in any office.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:5.7pt;text-decoration:underline"><br><br>GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">CERTIFICATES OF STOCK.  The stock of the Corporation shall be represented by certificates unless the Board of Directors shall by resolution in accordance with applicable law provide that some or all of any class or series of stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the Corporation. Every holder of stock in the Corporation represented by certificates shall be entitled to have a certificate signed by, or in the name of the Corporation by, the Chairman of the Board of Directors or the Vice Chairman of the Board of Directors, or the President or a Vice President, and by the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary of the Corporation, certifying the number and class of shares of stock of the Corporation owned by such holder. Any or all of the signatures on the certificate may be a facsimile. The Board of Directors shall have the power to appoint one or more transfer agents and&#47;or registrars for the transfer or registration of certificates of stock of any class, and may require stock certificates to be countersigned or registered by one or more of such transfer agents and&#47;or registrars.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">SHARES WITHOUT CERTIFICATES.  If the Board of Directors chooses to issue shares of stock without certificates, the Corporation, if required by the Delaware General Corporation Law, shall, within a reasonable time after the issue or transfer of shares without certificates, send the stockholder a written statement of the information required by the Delaware General Corporation Law. The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by electronic or other means not involving the issuance of certificates, provided the use of such system by the Corporation is permitted in accordance with applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">LOST CERTIFICATES.  Unless otherwise provided by the Amended and Restated Certificate of Incorporation, a new certificate of stock or uncertificated shares may be issued in the place of any certificate theretofore issued by the Corporation alleged to have been lost, stolen, destroyed or mutilated, and (in the case of any certificate alleged to be lost, stolen or destroyed) the Board of Directors may, in its discretion, require the owner thereof or his legal representatives, to give the Corporation a bond, in such sum as the Board of Directors may direct, sufficient to indemnify the Corporation against any claim that may be made against it with respect to any such certificate, prior to the issuance of any new certificate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">TRANSFER OF SHARES.  Shares of stock of the Corporation shall be transferable upon its books by the holders thereof, in person or by their duly authorized attorneys or legal representatives, upon surrender to the Corporation by delivery thereof (to the extent evidenced by a physical stock certificate) to the person in charge of the stock and transfer books and ledgers. Certificates representing such shares, if any, shall be cancelled and new certificates, if the shares are to be certificated, shall thereupon be issued. Shares of capital stock of the Corporation that are not represented by a certificate shall be transferred in accordance with applicable law. A record shall be made of each transfer. Whenever any transfer of shares shall be made for collateral security, and not absolutely, it shall be so expressed in the entry of the transfer if, when the certificates are presented, both the transferor and transferee request the Corporation to do so. The Board of Directors shall have power and authority to make such rules and regulations as it may deem necessary or proper concerning the issue, transfer and registration of certificates for shares of stock of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">STOCKHOLDER RECORD DATE.  In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment of any rights or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which, unless otherwise required by law, shall not be more than sixty nor less than ten days before the date of such meeting, nor more than sixty days prior to any such other action. If the Board of Directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held, and, for determining stockholders entitled to receive payment of any dividend or other distribution or allotment of rights or to exercise any rights of change, conversion or exchange of stock or for any other purpose, the record date shall be at the close of business on the day on which the Board of Directors adopts a resolution relating thereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to an adjournment of the meeting&#59; provided, however, that the Board of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Directors may fix a new record date for the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise restricted by the Amended and Restated Certificate of Incorporation, in order that the Corporation may determine the stockholders entitled to express consent to corporate action in writing without a meeting, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. If no record date for determining stockholders entitled to express consent to corporate action in writing without a meeting is fixed by the Board of Directors, (i) when no prior action of the Board of Directors is required by law, the record date for such purpose shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the Corporation in accordance with applicable law, and (ii) if prior action by the Board of Directors is required by law, the record date for such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">REGISTERED STOCKHOLDERS.  Prior to the surrender to the Corporation of the certificate or certificates for a share or shares of stock or notification to the Corporation of the transfer of uncertificated shares with a request to record the transfer of such share or shares, the Corporation may treat the registered owner of such share or shares as the person entitled to receive dividends, to vote, to receive notifications and otherwise to exercise all the rights and powers of an owner of such share or shares. To the fullest extent permitted by law, the Corporation shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">DIVIDENDS.  Subject to the provisions of law and the provisions of the Amended and Restated Certificate of Incorporation or any resolution or resolutions adopted by the Board of Directors pursuant to authority expressly vested in it by the Amended and Restated Certificate of Incorporation and Section 151 of the Delaware General Corporation Law, the Board of Directors may, to the fullest extent permitted by law, declare dividends upon the capital stock of the Corporation. Before declaring any dividend there may be set apart out of any funds of the Corporation legally available for dividends, such sum or sums as the Board of Directors from time to time in its discretion deem proper for working capital, future capital needs or as a reserve fund to meet contingencies or for such other purposes as the Board of Directors shall deem appropriate or in the interests of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">SEAL.  The Board of Directors may provide a suitable seal, containing the name of the Corporation and the words &#8220;CORPORATE SEAL DELAWARE&#8221;. Such seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.36pt">FACSIMILE SIGNATURES.  In addition to the provisions for use of facsimile signatures elsewhere specifically authorized in these By-laws, facsimile signatures of any officer or officers of the Corporation may be used whenever and as authorized by the Board of Directors or a committee thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">RELIANCE UPON BOOKS, REPORTS AND RECORDS.  Each director, each member of any committee designated by the Board of Directors, and each officer of the Corporation shall, in the performance of his duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation and upon such information, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">opinions, reports or statements made to the Corporation by any of its officers, or employees, or committees of the Board of Directors, or by any other person as to matters the member reasonably believes are within such other person&#8217;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">FISCAL YEAR.  The fiscal year of the Corporation shall end on January 31 in each year, and shall be subject to change, by resolution of the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">CHECKS.  All checks, drafts or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the Corporation shall be signed by such officer or officers, agent or agents of the Corporation, and in such manner, as shall be determined from time to time by resolution of the Board of Directors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">NOTICE AND WAIVER OF NOTICE.   Except as otherwise provided in this Section 13, whenever any notice is required to be given, personal notice is not meant unless expressly so stated, and any notice so required shall be deemed to be sufficient if deposited in the United States mail, postage prepaid, addressed to the person entitled thereto at his address as it appears on the records of the Corporation, and such notice shall be deemed to have been given on the day of such mailing. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided in Section 232 of the Delaware General Corporation Law. Stockholders not entitled to vote shall not be entitled to receive notice of any meetings except as otherwise required by law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Whenever any notice is required to be given under the provisions of any law, or under the provisions of the Amended and Restated Certificate of Incorporation or these By-laws, a waiver thereof in writing, or by telegraph, fax or similar form of telecommunication or electronic transmission, whether before or after the time stated therein, shall be deemed equivalent thereto. Neither the business nor the purpose of any meeting needs to be specified in such a waiver. Attendance at any meeting (in person or by remote communication) shall constitute waiver of notice except attendance for the sole purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">TIME PERIODS.  In applying any provision of these By-laws which requires that an act be done or not done a specified number of days prior to an event or that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the doing of the act shall be excluded, and the day of the event shall be included.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">SECTION HEADINGS.  Section headings in these By-laws are for convenience of reference only and shall not be given any substantive effect in limiting or otherwise construing any provision herein.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt">INCONSISTENT PROVISIONS.  In the event that any provision of these By-laws is or becomes inconsistent with any provision of the Amended and Restated Certificate of Incorporation, the Delaware General Corporation Law or any other applicable law, such provision of these By-laws shall not be given any effect to the extent of such inconsistency but shall otherwise be given full force and effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:1.04pt;text-decoration:underline"><br><br>AMENDMENTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board of Directors is authorized to make, repeal, alter, amend change, add to and rescind, in whole or in part, these By-laws without the assent or vote of the stockholders in any manner not inconsistent with the laws of the State of Delaware or the Amended and Restated Certificate of Incorporation. The stockholders may amend or repeal these Bylaws, or adopt new bylaws, even though the Bylaws also may be amended or repealed, or new bylaws also may be adopted, by the Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:32.38pt;text-decoration:underline"><br><br>INDEMNIFICATION OF DIRECTORS AND OFFICERS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by reason of the fact that he or she or a person of whom he or she is the legal representative is or was a director or an officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, agent or trustee of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (hereinafter an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee, agent trustee or representative or in any other capacity while serving as a director, officer, employee, agent trustee or representative, shall be indemnified and held harmless by the Corporation to the fullest extent permitted by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to such amendment), against all expense, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith&#59; provided, however, that, except as provided in this Article VII with respect to proceedings to enforce rights to indemnification and &#8220;advancement of expenses&#8221; (as defined below) or with respect to any compulsory counterclaim brought by such indemnitee, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the right to indemnification conferred in this Article VII, an indemnitee shall also have the right to be paid by the Corporation the expenses (including attorneys&#8217; fees) incurred in appearing at, participating in or defending any such proceeding in advance of its final disposition or in connection with a proceeding brought to establish or enforce a right to indemnification or advancement of expenses under this Article VII (hereinafter an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">advancement of expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, that, if the Delaware General Corporation Law requires or in the case of an advance made in a proceeding brought to establish or enforce a right to indemnification or advancement, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking (hereinafter an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">undertaking</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">final adjudication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that such indemnitee is not entitled to be indemnified or entitled to advancement for such expenses under this Article VII or otherwise. If a claim under </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Article VII is not paid in full by the Corporation within sixty (60) days after a written claim for indemnification has been received by the Corporation, and in the case of a claim for an advancement of expenses, within twenty (20) days, the indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim or to obtain advancement of expenses, as applicable. To the fullest extent permitted by law, if successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard for indemnification set forth in the Delaware General Corporation Law. Neither the failure of the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the Corporation (including its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VII or otherwise shall be on the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provision of indemnification to or the advancement of expenses and costs to any indemnitee under this Article VII, or the entitlement of any indemnitee to indemnification or advancement of expenses and costs under this Article VII, shall not limit or restrict in any way the power of the Corporation to indemnify or advance expenses and costs to such indemnitee in any other way permitted by law or be deemed exclusive of, or invalidate, any right to which any indemnitee seeking indemnification or advancement of expenses and costs may be entitled under any law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such indemnitee&#8217;s capacity as an officer, director, employee or agent of the Corporation and as to action in any other capacity.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Given that certain jointly indemnifiable claims (as defined below) may arise due to the service of the indemnitee as a director of the Corporation at the request of the indemnitee-related entities (as defined below), the Corporation shall be fully and primarily responsible for the payment to the indemnitee in respect of indemnification or advancement of expenses in connection with any such jointly indemnifiable claims, pursuant to and in accordance with the terms of this Article VII, irrespective of any right of recovery the indemnitee may have from the indemnitee-related entities. Under no circumstance shall the Corporation be entitled to any right of subrogation or contribution by the indemnitee-related entities and no right of advancement or recovery the indemnitee may have from the indemnitee-related entities shall reduce or otherwise alter the rights of the indemnitee or the obligations of the Corporation hereunder. In the event that any of the indemnitee-related entities shall make any payment to the indemnitee in respect of indemnification or advancement of expenses with respect to any jointly indemnifiable claim, the indemnitee-related entity making such payment shall be subrogated to the extent of such payment to all of the rights of recovery of the indemnitee against the Corporation, and the indemnitee shall execute all papers reasonably required and shall do all things that may be reasonably necessary to secure such rights, including the execution of such documents as may be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">necessary to enable the indemnitee-related entities effectively to bring suit to enforce such rights. Each of the indemnitee-related entities shall be third-party beneficiaries with respect to this paragraph of this Article VII, entitled to enforce this paragraph of this Article VII.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Article VII, the following terms shall have the following meanings&#58; The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">indemnitee-related entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise (other than the Corporation or any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise for which the indemnitee has agreed, on behalf of the Corporation or at the Corporation&#8217;s request, to serve as a director, officer, employee or agent and which service is covered by the indemnity described herein) from whom an indemnitee may be entitled to indemnification or advancement of expenses with respect to which, in whole or in part, the Corporation may also have an indemnification or advancement obligation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">jointly indemnifiable claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be broadly construed and shall include, without limitation, any action, suit or proceeding for which the indemnitee shall be entitled to indemnification or advancement of expenses from both the indemnitee-related entities and the Corporation pursuant to Delaware law, any agreement or certificate of incorporation, by-laws, partnership agreement, operating agreement, certificate of formation, certificate of limited partnership or comparable organizational documents of the Corporation or the indemnitee-related entities, as applicable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this Article VII with respect to the indemnification and advancement of expenses of directors and officers of the Corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The rights conferred upon indemnitees in this Article VII shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer or trustee and shall inure to the benefit of the indemnitee&#8217;s heirs, executors and administrators. Any amendment, alteration or repeal of this Article VII that adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit or eliminate any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act that took place prior to such amendment or repeal.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hqy-20230210.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fda000f7-2668-4810-8794-b37fb50dca9e,g:6ac9371a-f328-4ee1-8801-2a5ce3187201-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hqy="http://healthequity.com/20230210" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20230210">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20230210_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20230210_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthequity.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hqy-20230210_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fda000f7-2668-4810-8794-b37fb50dca9e,g:6ac9371a-f328-4ee1-8801-2a5ce3187201-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_a6c34484-a212-42e5-a607-df006418c235_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_059fadd2-158a-4ed2-baf8-39aef37e7d83_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9a134ee7-5ca4-4530-ad02-afb8c551cecc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5329e98a-642c-45c0-949d-f3a694f896d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cb7fc033-942a-4826-b7fd-0a01cec9d8b7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aec0df31-16dc-486c-8997-c5ed85de7eb8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f69218e1-297c-43cc-a378-0ceeba529547_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_b3cacf23-767c-44b8-8630-b2d340771caa_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7d35f01a-ade3-4904-9fe6-ee4479cd1341_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_83a2cfd0-b4ab-4475-bed5-b381ab36b898_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c086b816-04fd-4787-8e2e-3173166619bb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_bcf35d65-8803-4a14-aebe-89fb10b01cdd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5eb79e3e-f52a-4ccf-a496-e659b2b7d7af_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f76c2954-723f-4db7-8e7c-8fdec86b34bc_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_acd4a264-ecda-43ea-ba63-3aab075d7302_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_115c6dd0-f30f-45dc-84f9-beac842020fe_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_32655b91-4385-48a0-a26c-88a3df5822b9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f593f411-4aa0-4ff4-9b92-a3ea6d7ec8d0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e033faa5-831f-460a-afff-fac81f4369f3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ca56b59b-a8ca-40cd-93c3-50f8c1e18656_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d44550b7-9e33-4e2a-8ddd-df3c0b6ae72d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5208df89-d610-4022-8973-676dd2b8559e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2a626585-1fc2-4443-9e7f-2cf925f251a9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5bd52436-042a-42ca-9e3e-e6075876ca82_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_b32d0b77-07a5-454b-9642-4d2667243237_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hqy-20230210_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fda000f7-2668-4810-8794-b37fb50dca9e,g:6ac9371a-f328-4ee1-8801-2a5ce3187201-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20230210.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b9043b00-218b-40c1-bcdc-6e843a2778b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_DocumentType_b9043b00-218b-40c1-bcdc-6e843a2778b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9e8aab39-ec82-4ca9-88a2-0d778df0e0c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_DocumentPeriodEndDate_9e8aab39-ec82-4ca9-88a2-0d778df0e0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_23a98201-3b8c-4c55-afe8-78559c9221bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityFileNumber_23a98201-3b8c-4c55-afe8-78559c9221bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_609c3e08-b3e9-440f-803e-5a7a5c7b0718" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityRegistrantName_609c3e08-b3e9-440f-803e-5a7a5c7b0718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2ea323b7-1aac-4006-872e-05d535d94770" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2ea323b7-1aac-4006-872e-05d535d94770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8776f36e-1ffa-43c7-9d5c-4b4b8d264bc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityTaxIdentificationNumber_8776f36e-1ffa-43c7-9d5c-4b4b8d264bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9eb83979-ddd2-40ac-bc3f-77c3679590ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityAddressAddressLine1_9eb83979-ddd2-40ac-bc3f-77c3679590ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_38ec6726-76f4-4ca5-b41c-e2f11f887885" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityAddressAddressLine2_38ec6726-76f4-4ca5-b41c-e2f11f887885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_67a60775-d26d-4395-adb2-0aa7c039950f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityAddressCityOrTown_67a60775-d26d-4395-adb2-0aa7c039950f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b822de28-a85f-4175-a58d-b5a7ef470db3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityAddressStateOrProvince_b822de28-a85f-4175-a58d-b5a7ef470db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fd9b622e-c1d5-42d5-baa2-7e46b0c49f16" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityAddressPostalZipCode_fd9b622e-c1d5-42d5-baa2-7e46b0c49f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6e86167d-c983-42da-aa98-8811366774a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_CityAreaCode_6e86167d-c983-42da-aa98-8811366774a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1767f559-d9f4-4216-adc4-3b816bd1488a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_LocalPhoneNumber_1767f559-d9f4-4216-adc4-3b816bd1488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_86317e8e-7dda-4f61-96f8-59261c4ea187" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_WrittenCommunications_86317e8e-7dda-4f61-96f8-59261c4ea187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b163bdca-8c68-4d7e-a002-0485dd58c774" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_SolicitingMaterial_b163bdca-8c68-4d7e-a002-0485dd58c774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_5ef806ba-449f-43f7-a1fc-e1130c2bc030" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_PreCommencementTenderOffer_5ef806ba-449f-43f7-a1fc-e1130c2bc030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_04fb3368-0849-4e65-8c50-d5991b2a01cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_04fb3368-0849-4e65-8c50-d5991b2a01cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9fa0552f-b642-4ba1-ad6e-ffad79e6e13a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_Security12bTitle_9fa0552f-b642-4ba1-ad6e-ffad79e6e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_954cff04-61be-46e2-9d03-407e3b8aba40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_TradingSymbol_954cff04-61be-46e2-9d03-407e3b8aba40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ac4b80b6-c029-431f-8838-14ec24f52d01" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_SecurityExchangeName_ac4b80b6-c029-431f-8838-14ec24f52d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_12accf8d-0556-4b81-a516-ea5da04eef83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityEmergingGrowthCompany_12accf8d-0556-4b81-a516-ea5da04eef83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_93f28e2b-e11b-4070-9e0e-78146c8511f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_EntityCentralIndexKey_93f28e2b-e11b-4070-9e0e-78146c8511f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_82776359-0445-4149-949f-b1f98a605ebc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_AmendmentFlag_82776359-0445-4149-949f-b1f98a605ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1d10bf7e-97b4-4e4f-9c76-8b5c491a84f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_606796a2-9ac9-48cc-8701-3f1305b2a785" xlink:to="loc_dei_CurrentFiscalYearEndDate_1d10bf7e-97b4-4e4f-9c76-8b5c491a84f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140100410630928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 10,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHEQUITY, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--01-31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>hqy-20230210_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20230210.xsd" xlink:type="simple"/>
    <context id="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2023-02-10</startDate>
            <endDate>2023-02-10</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF8yLTEtMS0xLTY0NTI3_e47efa5c-9992-4d12-8cd8-515ed9182cda">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF8zLTEtMS0xLTY0NTI3_c1c86f4d-a37c-4b55-af63-bc0b52a5a445">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV80L2ZyYWc6Y2M5ODkwZDE3MjQ2NDlhNmJhMWZmYjg5YWU2OWM5MzgvdGFibGU6M2VlNTNkMDZkZThjNGJmMjliZWMyMDY4ZmZhNjhiZTAvdGFibGVyYW5nZTozZWU1M2QwNmRlOGM0YmYyOWJlYzIwNjhmZmE2OGJlMF80LTEtMS0xLTY2MjYy_a0fc5e8e-b3fd-4e27-8d1a-a6a397c55f79">--01-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y184Mw_34666b39-1e33-4078-82b5-65a187357ec7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMjU_8fc2ef7e-a2c4-42e5-8bd3-250c7e83d469">2023-02-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6ZGQ4YjNlNTNlZjljNGI3ZGJhNzIxODA1YzhhNGI4ZjgvdGFibGVyYW5nZTpkZDhiM2U1M2VmOWM0YjdkYmE3MjE4MDVjOGE0YjhmOF8xLTAtMS0xLTY0NTI3_f9213d0a-5dce-40ef-ad38-8c4bc02e0337">HEALTHEQUITY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTAtMS0xLTY0NTI3_73aed8fc-66bc-452f-834f-5ca9657823d5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTItMS0xLTY0NTI3_eeabe0c5-dbff-4e49-becf-d1b18d920462">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTJlNDg2OWQxNDk0NGFkNDk5MWZmYzgwNjEzMzQ2NzIvdGFibGVyYW5nZToxMmU0ODY5ZDE0OTQ0YWQ0OTkxZmZjODA2MTMzNDY3Ml8wLTQtMS0xLTY0NTI3_a3234ded-b4f9-4ddd-9344-db271dcae16f">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMzU_f7bc20da-c58d-4f52-99d8-0d31f8c750ad">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yMzk_37fc50b8-6380-4783-916e-a2f01000ad08">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNDM_ad98a350-4729-4fee-b8ab-b510188b1381">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNDc_229b9f5f-80b0-4615-bc46-b73ab86c08e4">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTA_2f5ca597-faff-46bd-9fbc-efd9c8c164f7">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTU_3abe499d-949a-425a-ad92-2bf99774eecb">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18yNTk_7a10be43-55a9-4da3-8479-cb77cd3965a2">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y182NjY_e35a36a3-7d95-45dd-8302-cde222253c10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y183NTU_352f894d-095b-4e52-b278-145f33d8f860">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y184NDU_1d68a0d6-2e59-44ad-997a-281816508d32">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y185NTE_0830d535-9291-4962-a1f0-21a2e793989a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTAtMS0xLTY0NTI3_c0936bcf-cb02-4fce-a83d-e2c465d7cf09">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTEtMS0xLTY0NTI3_094b4249-3db1-417e-80f0-26c98dc206e5">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGFibGU6MTE0YWUwNDdmZTE1NGY3NTg1YTkzNmQxMzUyNDhkM2YvdGFibGVyYW5nZToxMTRhZTA0N2ZlMTU0Zjc1ODVhOTM2ZDEzNTI0OGQzZl8xLTItMS0xLTY0NTI3_c9fcb365-8970-497b-8f19-48bad7fb70f7">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyMjhiOGZmM2QyMDQ2M2RhYjYzYWFjOTUyMzQxMGQxL3NlYzphMjI4YjhmZjNkMjA0NjNkYWI2M2FhYzk1MjM0MTBkMV8xL2ZyYWc6ZDFiNTg2ZTMzYmY3NDc0Njg4Yzc2M2I5YmFkYTVlNWMvdGV4dHJlZ2lvbjpkMWI1ODZlMzNiZjc0NzQ2ODhjNzYzYjliYWRhNWU1Y18xMzY0_c8ea0b42-d730-4127-9ff0-7e4c3131b6f9">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( "B 2E9O.FK7[0   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( "B 2E:97)PC$ 8  )PG   3
M      "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ *(!*
M5L2D2B^$!   P1$  !@              ("!# @  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( "B 2E:?H!OPL0(  .(,   -
M      "  <8,  !X;"]S='EL97,N>&UL4$L! A0#%     @ *(!*5I>*NQS
M    $P(   L              ( !H@\  %]R96QS+RYR96QS4$L! A0#%
M  @ *(!*5AE%%?4W 0  )P(   \              ( !BQ   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( "B 2E8D'INBK0   /@!   :
M  "  >\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M "B 2E9ED'F2&0$  ,\#   3              "  =02  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  !X4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hqy-20230210.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hqy-20230210.htm">hqy-20230210.htm</File>
    <File>healthequityinc_amendedand.htm</File>
    <File>hqy-20230210.xsd</File>
    <File>hqy-20230210_lab.xml</File>
    <File>hqy-20230210_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hqy-20230210.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "hqy-20230210.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20230210_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20230210_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20230210.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20230210",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20230210.htm",
      "contextRef": "i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://healthequity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20230210.htm",
      "contextRef": "i37311d92a12c49488d1b0766afe39f1b_D20230210-20230210",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001428336-23-000005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001428336-23-000005-xbrl.zip
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M 6>3"2\6>\F/EYI_5ZG]"2/+DN^)8.ZR NQ&TNC.5F!)YE>;N^[+98YI6W<
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M ^VIW,I@_;\ (?ALH]5YOO.I D_PO]VFT .;M7#@D5:93JL>M<%QPW0%@3*
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M79O;,+^IRCL,X"?3<M'X-EX@P>$E-!Z76: X<S"/H.9M;[6O?$?V2:TK:BZ
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MU@7F32//A$LM9U&'<ZMML3UH16+B?*N%<@NI%A& K7BKR:0RUQH;(KFA>BN
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M:A3Q'XC<)U'%1EV<>8\=1A#SYA,(4^04@%GCI1N+\BXKES6 :FEW]O<N9&3
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MXZ$L2*?L@SX;9V:#4A ;3CJN(8$);<UDQJ18T_W%SFT=<V=92EZG<^YD"BY
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MZ[0)UNF-A\-#8[(9AW&6>!7Y:FOK,CA,MF$91RS7.^010ES]^A@RN-B <H%
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MA,!N1OI7=9!V'72Q?EI3).O.C _]DG #7J3C!1JRE=%P2*L&7P'&3\PX"0<
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MD"N@)S.,5;]<+V%L&3G;@&4HE@YG%N'>@_NW79N,05)'P!_]_-D/4D0^BF
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MK .?.&!D:6H*!!F:,=9="Z,S_<&>=>(1H<.D?"!XGC$?:^RK2^ >Y\383SL
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M1L>RJWT%B:=C!1,Q>/HM"L'M WXE1&3$+_T8VH'0I0-'<#1U''%[A:@L/B'
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M'>Y]S^<NNHGQ9I=;1<O$L>27W6ML/\H2?ST>7<D.V03^>$D_V/U_4$L#!!0
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M#>0/1$IJVM6G\[9E':5MC+V2FSD+]@=MO=\91F=83_AD\ M02P,$%     @
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M961A;F0N:'1M4$L! A0#%     @ *(!*5AQI,*;*%0  RH@  !
M     ( !'58  &AQ>2TR,#(S,#(Q,"YH=&U02P$"% ,4    "  H@$I6REEE
MYW$"  !X!P  $               @ $5;   :'%Y+3(P,C,P,C$P+GAS9%!+
M 0(4 Q0    ( "B 2E8XX<?Q'PL  "9F   4              "  ;1N  !H
M<7DM,C R,S R,3!?;&%B+GAM;%!+ 0(4 Q0    ( "B 2E8$.>QI$P<  !@U
M   4              "  05Z  !H<7DM,C R,S R,3!?<')E+GAM;%!+!08
1    !0 % $P!  !*@0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
